The pharmaceutical analytical-testing sector has experienced significant change over the past few years, largely as a result of global contamination and economically motivated adulteration. Industry and regulators have moved quickly to update standards, guidelines, and monographs to help prevent future drug-product safety breaches.

This webinar highlights the changes affecting industry in the area of melamine testing and related contamination issues, including recent FDA guidance, USP monographs, and international harmonization efforts.

Participants in the June 29th webinar included:IPEC-Americas past chair David Schoneker(Colorcon)and two FDA CDER officials, Dr. Steven Wolfgang and Brian Hasselbalch.

Click here to register and view Pharm Tech webinar